[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100520680":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":33,"centralContacts":37,"locations":45,"responsibleParty":100,"collaborators":103,"id":107,"slug":108,"hasResults":109,"nctId":110,"briefTitle":111,"officialTitle":111,"acronym":112,"eligibilityCriteria":113,"healthyVolunteers":109,"sex":114,"minAge":115,"maxAge":116,"enrollmentInfo":117,"targetDuration":32,"studyType":120,"phases":121,"briefSummary":123,"conditions":124,"keywords":32,"overallStatus":48,"whyStopped":32,"lastUpdateSubmitDate":126,"lastUpdatePostDateStruct":127,"startDateStruct":130,"completionDateStruct":132,"leadSponsor":134,"locationsCount":135},{"fullName":5,"class":6},"Columbia University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of Care","ACTIVE_COMPARATOR","Participants will be provided with continuous Telehealth dietitian follow-up",[13],"Behavioral: Continuous telemedicine monitoring",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard of Care Plus Technology","EXPERIMENTAL","In addition to standard of care, participants will be provided with gluten detection technology so as to assist in navigating the gluten-free diet.",[19,13],"Behavioral: Gluten detection technology",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","Gluten detection technology","Portable technology to sense gluten after ingestion",[15],[27],"Gluten Detect",{"type":22,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"Continuous telemedicine monitoring","Regular follow-up with an expert dietitian",[9,15],null,[34],{"name":35,"affiliation":5,"role":36},"Benjamin Lebwohl, MD, MS","PRINCIPAL_INVESTIGATOR",[38,42],{"name":35,"role":39,"phone":40,"phoneExt":32,"email":41},"CONTACT","212-305-9338","BL114@cumc.columbia.edu",{"name":43,"role":39,"phone":44,"phoneExt":32,"email":32},"Randi Wolf, PhD, MPH","212-678-3912",[46,64,77,86],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"University of Chicago Medical Center","RECRUITING","Chicago","Illinois","60637","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-87.65005,41.85003,{"lat":58,"lon":57},[61],{"name":62,"role":39,"phone":63,"phoneExt":32,"email":32},"Sonia Kupfer, MD","773-834-1438",{"facility":65,"status":48,"city":66,"state":67,"zip":68,"country":52,"countryCode":53,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Beth Israel Deaconess Medical Center","Boston","Massachusetts","02215",{"type":55,"coordinates":70},[71,72],-71.05977,42.35843,{"lat":72,"lon":71},[75],{"name":76,"role":39,"phone":32,"phoneExt":32,"email":32},"Jocelyn Silvester, MD, PhD",{"facility":78,"status":48,"city":79,"state":79,"zip":80,"country":52,"countryCode":53,"cosmosGeoPoint":81,"geoPoint":85,"contacts":32},"Columbia University Irving Medical Center","New York","10032",{"type":55,"coordinates":82},[83,84],-74.00597,40.71427,{"lat":84,"lon":83},{"facility":87,"status":48,"city":88,"state":89,"zip":90,"country":52,"countryCode":53,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"Vanderbilt University Medical Center","Nashville","Tennessee","37232",{"type":55,"coordinates":92},[93,94],-86.78444,36.16589,{"lat":94,"lon":93},[97],{"name":98,"role":39,"phone":99,"phoneExt":32,"email":32},"Dawn Adams, MD","615-936-0192",{"type":36,"investigatorFullName":101,"investigatorTitle":102,"investigatorAffiliation":5,"oldNameTitle":32,"oldOrganization":32},"Benjamin Lebwohl","Professor",[104],{"name":105,"class":106},"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","NIH","100520680","gluten-technology-and-education-for-celiac-health-100520680",false,"NCT06059716","Gluten Technology and Education for Celiac Health","GLUTECH","Inclusion Criteria:\n\n* Any gender; Age 18-75 years\n* Celiac disease diagnosis by serology and duodenal biopsy (corresponding to •Marsh 3 histology), adequate sampling and interpretable villus height to crypt depth ratio upon review by our study pathologist\n* Diagnosed with celiac disease within 4 months of initial study screening\n* Willingness to use gluten-detection technology\n* Not currently using a gluten detection technology that tests for gluten in urine or stool\n\nExclusion Criteria:\n\n* Currently pregnant or planning to become pregnant during the study\n* Not planning to follow a gluten-free diet\n* Concurrent participation in a clinical trial of an experimental pharmacologic agent (for any condition).","ALL","18 Years","75 Years",{"count":118,"type":119},200,"ESTIMATED","INTERVENTIONAL",[122],"NA","The investigators propose to plan for a multi-center randomized controlled trial (M-RCT) to test the effectiveness of novel gluten detection technologies as an adjunct to telemedicine to manage celiac disease in newly diagnosed adults. If successful, the proposed intervention will improve mucosal recovery, promote a shift in current practice of celiac disease management toward long-term monitoring, and represent a significant step toward reducing the severe physical and psychological consequences of celiac disease.",[125],"Celiac Disease","2026-06-08",{"date":128,"type":129},"2026-06-10","ACTUAL",{"date":131,"type":129},"2024-10-08",{"date":133,"type":119},"2028-08-31",{"name":5,"class":6},4]